182 related articles for article (PubMed ID: 32923873)
1. Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program.
Katsoulakis E; Duffy JE; Hintze B; Spector NL; Kelley MJ
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923873
[TBL] [Abstract][Full Text] [Related]
2. Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program.
Vashistha V; Armstrong J; Winski D; Poonnen PJ; Hintze B; Price M; Snowdon JL; Weeraratne D; Brotman D; Jackson GP; Kelley MJ
JCO Oncol Pract; 2021 Jul; 17(7):e1012-e1020. PubMed ID: 33780286
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of target gene exon sequencing by cognitive technology using a next generation sequencing platform in patients with lung cancer.
Chen Y; Yan W; Xie Z; Guo W; Lu D; Lv Z; Zhang X
Mol Clin Oncol; 2021 Feb; 14(2):36. PubMed ID: 33414916
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Clinical Genome Sequence Analysis by Watson for Genomics.
Itahashi K; Kondo S; Kubo T; Fujiwara Y; Kato M; Ichikawa H; Koyama T; Tokumasu R; Xu J; Huettner CS; Michelini VV; Parida L; Kohno T; Yamamoto N
Front Med (Lausanne); 2018; 5():305. PubMed ID: 30474028
[No Abstract] [Full Text] [Related]
5. A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing.
Sakai K; Takeda M; Shimizu S; Takahama T; Yoshida T; Watanabe S; Iwasa T; Yonesaka K; Suzuki S; Hayashi H; Kawakami H; Nonagase Y; Tanaka K; Tsurutani J; Saigoh K; Ito A; Mitsudomi T; Nakagawa K; Nishio K
Sci Rep; 2019 Aug; 9(1):11340. PubMed ID: 31383922
[TBL] [Abstract][Full Text] [Related]
6. Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program.
Vashistha V; Poonnen PJ; Snowdon JL; Skinner HG; McCaffrey V; Spector NL; Hintze B; Duffy JE; Weeraratne D; Jackson GP; Kelley MJ; Patel VL
PLoS One; 2020; 15(7):e0235861. PubMed ID: 32706774
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
Zugazagoitia J; Ramos I; Trigo JM; Palka M; Gómez-Rueda A; Jantus-Lewintre E; Camps C; Isla D; Iranzo P; Ponce-Aix S; García-Campelo R; Provencio M; Franco F; Bernabé R; Juan-Vidal O; Felip E; de Castro J; Sanchez-Torres JM; Faul I; Lanman RB; Garrido P; Paz-Ares L
Ann Oncol; 2019 Feb; 30(2):290-296. PubMed ID: 30535340
[TBL] [Abstract][Full Text] [Related]
8. Genomic Analysis of Metastatic Solid Tumors in Veterans: Findings From the VHA National Precision Oncology Program.
Poonnen PJ; Duffy JE; Hintze B; Shukla M; Brettin TS; Conrad NR; Yoo H; Guertin C; Looney JA; Vashistha V; Kelley MJ; Spector NL
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914016
[TBL] [Abstract][Full Text] [Related]
9. Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
Patel NM; Michelini VV; Snell JM; Balu S; Hoyle AP; Parker JS; Hayward MC; Eberhard DA; Salazar AH; McNeillie P; Xu J; Huettner CS; Koyama T; Utro F; Rhrissorrakrai K; Norel R; Bilal E; Royyuru A; Parida L; Earp HS; Grilley-Olson JE; Hayes DN; Harvey SJ; Sharpless NE; Kim WY
Oncologist; 2018 Feb; 23(2):179-185. PubMed ID: 29158372
[TBL] [Abstract][Full Text] [Related]
11. OncoKB: A Precision Oncology Knowledge Base.
Chakravarty D; Gao J; Phillips SM; Kundra R; Zhang H; Wang J; Rudolph JE; Yaeger R; Soumerai T; Nissan MH; Chang MT; Chandarlapaty S; Traina TA; Paik PK; Ho AL; Hantash FM; Grupe A; Baxi SS; Callahan MK; Snyder A; Chi P; Danila D; Gounder M; Harding JJ; Hellmann MD; Iyer G; Janjigian Y; Kaley T; Levine DA; Lowery M; Omuro A; Postow MA; Rathkopf D; Shoushtari AN; Shukla N; Voss M; Paraiso E; Zehir A; Berger MF; Taylor BS; Saltz LB; Riely GJ; Ladanyi M; Hyman DM; Baselga J; Sabbatini P; Solit DB; Schultz N
JCO Precis Oncol; 2017 Jul; 2017():. PubMed ID: 28890946
[TBL] [Abstract][Full Text] [Related]
12. The landscape of actionable genomic alterations in lung adenocarcinomas in India.
Sharma R; Kamireddy AP; Hussaini SM; Chatterjee S; Hasan Q; Jain J
Front Genet; 2023; 14():1256756. PubMed ID: 38155717
[TBL] [Abstract][Full Text] [Related]
13. Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
Ma LX; Espin-Garcia O; Bedard PL; Stockley T; Prince R; Mete O; Krzyzanowska MK
Thyroid; 2022 Jun; 32(6):657-666. PubMed ID: 35262412
[No Abstract] [Full Text] [Related]
14. [The characteristics of lung adenocarcinoma driver gene variants detected by high-throughput sequencing and quantitative fluorescence PCR].
Chen LF; Chen XY; Lin J; Yu XB; Jin L
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):772-778. PubMed ID: 31594041
[No Abstract] [Full Text] [Related]
15. Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering.
Snowdon JL; Weeraratne D; Huang H; Brotman D; Xue S; Willis VC; Lee YK; Jeon K; Zang DY; Kim HJ; Kim HY; Han B; Kim M
Medicine (Baltimore); 2021 Dec; 100(51):e27969. PubMed ID: 34941036
[TBL] [Abstract][Full Text] [Related]
16. Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study.
Normanno N; De Luca A; Abate RE; Morabito A; Milella M; Tabbò F; Curigliano G; Masini C; Marchetti P; Pruneri G; Guarneri V; Frassineti GL; Fasola G; Adamo V; Daniele B; Berardi R; Feroce F; Maiello E; Pinto C
Eur J Cancer; 2023 Jul; 187():174-184. PubMed ID: 37167765
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a Highly Curated Somatic Oncology Database to Aid in the Interpretation of Clinically Important Variants in Next-Generation Sequencing Results.
Yaung SJ; Krishna S; Xi L; Ju C; Palma JF; Schmid M
J Mol Diagn; 2020 Nov; 22(11):1356-1366. PubMed ID: 32961319
[TBL] [Abstract][Full Text] [Related]
18. Targeted mutation detection in breast cancer using MammaSeq™.
Smith NG; Gyanchandani R; Shah OS; Gurda GT; Lucas PC; Hartmaier RJ; Brufsky AM; Puhalla S; Bahreini A; Kota K; Wald AI; Nikiforov YE; Nikiforova MN; Oesterreich S; Lee AV
Breast Cancer Res; 2019 Feb; 21(1):22. PubMed ID: 30736836
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.
Cowzer D; Shah RH; Chou JF; Kundra R; Punn S; Fiedler L; DeMore A; Capanu M; Berger MF; Reidy-Lagunes D; Raj N
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38252063
[TBL] [Abstract][Full Text] [Related]
20. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
